Impact of Tardive Dyskinesia on Caregivers’ Well-Being and Daily Life
A team of investigators sought to assess the impact of patients’ symptoms of tardive dyskinesia on the individuals caring for them.
A team of investigators sought to assess the impact of patients’ symptoms of tardive dyskinesia on the individuals caring for them.
Investigators examined healthcare costs of adult patients with mild, moderate, moderately severe, and severe major depressive disorder and compare them with a control group representative of the general population.
Researchers conducted web-based focus groups to better understand patient preferences for medication management of a serious mental illness.
Investigators share outcomes from a virtual roundtable convened to discuss the effect of the COVID-19 pandemic on mental health and psychiatric care delivery.
Investigators participating in the TeleSCOPE study deployed a survey to evaluate the management of drug-induced movement disorders via telehealth during the COVID-19 pandemic.
Investigators assessed the impact of early-onset adverse childhood events on thalamic volume and subsequently the development of PTSD after trauma in adulthood.
Investigators used data from the Enroll-HD registry to assess patterns of treatment for chorea in patients with Huntington disease.
Researchers assessed adherence to treatment and hospital readmission rates in patients undergoing treatment with oral antipsychotics vs LAI paliperidone for schizophrenia.
A team of investigators sought to assess the efficacy of brexpiprazole as an adjunct to antidepressant treatment in patients with major depressive disorder and anxious distress.
A team of investigators assessed medical resource utilization among patients treated with either oral or long-acting injectable antipsychotic agents for schizophrenia.